A reduced physiological <sup>18</sup>F-fluorodeoxyglucose uptake in the brain and liver caused by malignant lymphoma being deprived of the tracer
-
- Otomi Yoichi
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Otsuka Hideki
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Shono Nahomi
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Onishi Hajime
- Department of Radiology, Tsurugi Municipal Handa Hospital, Tokushima, Japan
-
- Mitsuhashi Ryota
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Matsuzaki Saya
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Takaoka Yukiko
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Enomoto Hideaki
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Sakamoto Yuko
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Sasahara Mihoko
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Abe Takashi
- Department of Radiology, Nagoya University Hospital, Aichi, Japan
-
- Shinya Takayoshi
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
-
- Harada Masafumi
- Department of Radiology, Tokushima University Hospital, Tokushima, Japan
この論文をさがす
説明
<p>Purpose : To investigate whether or not the physiological brain and liver FDG uptake are decreased in patients with highly accelerated glycolysis lesions. Methods : We retrospectively analyzed 51 patients with malignant lymphoma. We compared the FDG uptake in the brain and liver of the patients with that in a control group. In 24 patients with a complete response (CR) or partial response (PR) to treatment, we compared the brain and liver uptake before and after treatment. Results : The maximum standardized uptake value (SUVmax) and total glycolytic volume (TGV) of the brain as well as the SUVmax and mean standardized uptake value (SUVmean) of the liver in malignant lymphoma patients were 13.1 ± 2.3, 7386.3 ± 1918.4, 3.2 ± 0.5, and 2.3 ± 0.4, respectively ; in the control group, these values were 14.9 ± 2.4, 8566.2 ± 1659.5, 3.4 ± 0.4, and 2.5 ± 0.3, respectively. The SUVmax and TGV of the brain and the SUVmean of the liver in malignant lymphoma patients were significantly lower than the control group. The SUVmax and TGV of the brain after treatment were significantly higher than before treatment. Both the SUVmax and SUVmean of liver after treatment were higher than before treatment, but not significant. Conclusion : A decreased physiological brain and liver FDG uptake is caused by highly accelerated lesion glycolysis. J. Med. Invest. 68 : 181-185, February, 2021</p>
収録刊行物
-
- The Journal of Medical Investigation
-
The Journal of Medical Investigation 68 (1.2), 181-185, 2021
国立大学法人 徳島大学医学部
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390006585528207872
-
- NII論文ID
- 130008038417
-
- NII書誌ID
- AA11166929
-
- ISSN
- 13496867
- 13431420
-
- PubMed
- 33994467
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可